Is Benfotiamine Effective Against Diabetic Complications?
Benfotiamine is a lipid soluble derivative of thiamine. Japanese researchers developed benfotiamine in the 1950’s and later patented it in the United States in 1962. No one in the US medical community paid much attention to it at the time. For the past 12 years in Europe it has been used for neuropathy, retinopathy and other uses. The chemical name and formula for benfotiamine is: S-benzoylthiamine-O-monophosphate (C19H23N4O6PS). It wasn’t until a group of researchers in New York at the Albert Einstein College of Medicine of Yeshiva University released the results of their research in 2003 in Nature Medicine Magazine did the rest of the world begin to take a look at this substance. Benfotiamine is unique and was reported by Michael Brownlee, M.D., as showing much promise in preventing nerve and blood-vessel damage in diabetics. Every diagnosed diabetic has been told by his/her healthcare provider that diabetic complications are the true killers in terms of diabetes. If you are a diabet
